Drug application
VITRASERT (GANCICLOVIR)
Drugs@FDA NDA 020569 · BAUSCH AND LOMB
Key facts
| Drug name | VITRASERT |
|---|---|
| Active ingredients | GANCICLOVIR |
| Application type | NDA |
| Application number | 020569 |
| Company | BAUSCH AND LOMB |
| Dosage forms | IMPLANT, IMPLANTATION |
| Strength | 4.5MG |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 3 - New Dosage Form |
| Latest submission status date | Mar 4, 1996 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.